Inari Medical (NASDAQ:NARI) Given New $65.00 Price Target at

Inari Medical (NASDAQ:NARI – Free Report) had its price target trimmed by Truist Financial from $70.00 to $65.00 in a report issued on Wednesday morning, Marketbeat reports. The brokerage currently has a hold rating on the stock. Separately, Robert W. Baird started coverage on shares of Inari Medical in a research note on Tuesday, July […]

Related Keywords

United States , Thomas Tu , Banque Cantonale Vaudoise , William Hoffman , Robertw Baird , Inari Medical Inc , Inari Medical Company Profile , Nasdaq , Parkside Financial Bank , Securities Exchange Commission , Belpointe Asset Management , Inari Medical , Free Report , Truist Financial , Moderate Buy , Get Free Report , Director William Hoffman , Exchange Commission , Capital Management , Financial Bank , Cantonale Vaudoise , Inari Medical Daily , Nasdaq Nari , Nari , Medical , Lower Price Target , Truist Financial Co ,